Empagliflozin (Compound)

Synonyms:Empagliflozin, 864070-44-0, JARDIANCE, BI 10773, BI-10773, Empagliflozin (BI 10773), BI10773, UNII-HDC1R2M35U, (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, HDC1R2M35U, 1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene, CHEBI:82720, (1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol, (2S,3R,4R,5S,6R)-2-[4-chloro-3-({4-[(3S)-oxolan-3-yloxy]phenyl}methyl)phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol, (1S)-1,5-anhydro-1-C-{4-chloro-3-((4-{((3S)-oxolan-3-yl)oxy}phenyl)methyl)phenyl}-D-glucitol, (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol, (2S,3R,4R,5S,6R)-2-[4-CHLORO-3-[[4-[(3S)-OXOLAN-3-YL]OXYPHENYL]METHYL]PHENYL]-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL, Empagliflozin [USAN:INN], MFCD22566222, Jardiance (TN), Tube106, (S)-Empagliflozin D4, BI-10773;Empagliflozin, Empagliflozin (BI10773), C23H27ClO7, SCHEMBL899986, GTPL4754, CHEMBL2107830, Empagliflozin (JAN/USAN/INN), AMY1858, EX-A414, BDBM150162, BBL104150, CE0108, s8022, STL557964, US8980829, EMPAGLIFLOZIN, ZINC36520252, AKOS024464680, CCG-269242, CS-0940, DB09038, DS-9824, PB23119, VA10802, (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol, AC-27643, HY-15409, SW219120-1, X5927, C22194, D10459, A852380, AU-004/43508285, Q5373824, Empagliflozin (BI-10773;BI 10773;BI10773), 1,5-anhydro-1-{4-chloro-3-[4-(tetrahydro-3-furanyloxy)benzyl]phenyl}hexitol, (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxyMethyl)-tetrahydro-2H-pyran-3,4,5-triol, (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (2S,3R,4R,5S,6R)-2-[4-Chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol, 7R3, D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-(((3S)-tetrahydro-3-furanyl)oxy)phenyl)methyl)phenyl)-, (1S)-

Pubchem:PUBCHEM:11949646

Id:11949646

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Empagliflozin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Empagliflozin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Empagliflozin.

Results found

Linked to

	Label	Description
	BRD-K53765467-001-02-1 Substance (Entity type)	A Substance
	empagliflozin (e91225f6-eda4-480c-960c-fe1554c023bd) Collection (Entity type)	Metadatata for empagliflozin
	DCSTRUCT ID 04830 Collection (Entity type)	DrugPage Collection: (DrugCentralID:04830; PubChem_CID:11949646, FILE=drugcentral_drug_04830.json)
	Empagliflozin negatively regulates DAPK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Empagliflozin positively regulates PROM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Empagliflozin negatively regulates APOE Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Empagliflozin positively regulates PITX1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Empagliflozin negatively regulates SKIC2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Empagliflozin positively regulates TUBB2A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Empagliflozin negatively regulates LGR4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS